The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Defects in IL-2R Signaling Contribute to Diminished Maintenance of FOXP3 Expression in CD4+CD25+ Regulatory T-Cells of Type 1 Diabetic Subjects
Open accessAbstract
OBJECTIVE: In humans, multiple genes in the interleukin (IL)-2/IL-2 receptor (IL-2R) pathway are associated with type 1 diabetes. However, no link between IL-2 responsiveness and CD4+CD25+FOXP3+ regulatory T-cells (Tregs) has been demonstrated in type 1 diabetic subjects despite the role of these IL-2–dependent cells in controlling autoimmunity. Here, we address whether altered IL-2 responsiveness impacts persistence of FOXP3 expression in Tregs of type 1 diabetic subjects. RESEARCH DESIGN AND METHODS: Persistence of Tregs was assessed by culturing sorted CD4+CD25hi natural Tregs with IL-2 and measuring FOXP3 expression over time by flow cytometry for control and type 1 diabetic populations. The effects of IL-2 on FOXP3 induction were assessed 48 h after activation of CD4+CD25− T-cells with anti-CD3 antibody. Cytokine receptor expression and signaling upon exposure to IL-2, IL-7, and IL-15 were determined by flow cytometry and Western blot analysis. RESULTS: Maintenance of FOXP3 expression in CD4+CD25+ Tregs of type 1 diabetic subjects was diminished in the presence of IL-2, but not IL-7. Impaired responsiveness was not linked to altered expression of the IL-2R complex. Instead, IL-2R signaling was reduced in Tregs and total CD4+ T-cells of type 1 diabetic subjects. In some individuals, decreased signal transducer and activator of transcription 5 phosphorylation correlated with significantly higher expression of protein tyrosine phosphatase N2, a negative regulator of IL-2R signaling. CONCLUSIONS: Aberrant IL-2R signaling in CD4+ T-cells of type 1 diabetic subjects contributes to decreased persistence of FOXP3 expression that may impact establishment of tolerance. These findings suggest novel targets for treatment of type 1 diabetes within the IL-2R pathway and suggest that an altered IL-2R signaling signature may be a biomarker for type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.019 · Cited by 2,291
A function for interleukin 2 in Foxp3-expressing regulatory T cells
Fontenot, J. D., Rasmussen, J. P., Gavin, M. A., & Rudensky, A. Y. (2005) · Nature Immunology · doi:10.1038/ni1263 · Cited by 1,819
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
Finland, G. O. T. 1. D. I., Todd, J. A., the Wellcome Trust Case Control Consortium, Walker, N. M., Cooper, J. D., Smyth, D. J., Downes, K., Plagnol, V., Bailey, R., Nejentsev, S., et al. (2007) · Nature Genetics · doi:10.1038/ng2068 · Cited by 1,456
Natural versus adaptive regulatory T cells
Bluestone, J. A., & Abbas, A. K. (2003) · Nature Reviews Immunology · doi:10.1038/nri1032 · Cited by 1,323
Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment
Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A., & Alt, F. W. (1995) · Immunity · doi:10.1016/1074-7613(95)90180-9 · Cited by 1,080
Malek, T. R. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090357 · Cited by 1,079
Deregulated T Cell Activation and Autoimmunity in Mice Lacking Interleukin-2 Receptor β
Suzuki, H., Kündig, T. M., Furlonger, C., Wakeham, A., Timms, E., Matsuyama, T., Schmits, R., Simard, J. J. L., Ohashi, P. S., Griesser, H., et al. (1995) · Science · doi:10.1126/science.7770771 · Cited by 871
Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes
Lindley, S., Dayan, C. M., Bishop, A., Roep, B. O., Peakman, M., & Tree, T. I. M. (2005) · Diabetes · doi:10.2337/diabetes.54.1.92 · Cited by 861
Burchill, M. A., Yang, J., Vogtenhuber, C., Blazar, B. R., & Farrar, M. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.280 · Cited by 834
Zorn, E., Nelson, E. A., Mohseni, M., Porcheray, F., Kim, H., Litsa, D., Bellucci, R., Raderschall, E., Canning, C., Soiffer, R. J., et al. (2006) · Blood · doi:10.1182/blood-2006-02-004747 · Cited by 740
Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune Destruction
Tang, Q., Adams, J. Y., Penaranda, C., Melli, K., Piaggio, E., Sgouroudis, E., Piccirillo, C. A., Salomon, B. L., & Bluestone, J. A. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.016 · Cited by 729
Baron, U., Floess, S., Wieczorek, G., Baumann, K., Grützkau, A., Dong, J., Thiel, A., Boeld, T. J., Hoffmann, P., Edinger, M., et al. (2007) · European Journal of Immunology · doi:10.1002/eji.200737594 · Cited by 694
Zheng, S. G., Wang, J., Wang, P., Gray, J. D., & Horwitz, D. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2018 · Cited by 597
Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci
Cooper, J. D., Smyth, D. J., Smiles, A. M., Plagnol, V., Walker, N. M., Allen, J. E., Downes, K., Barrett, J. C., Healy, B. C., Mychaleckyj, J. C., et al. (2008) · Nature Genetics · doi:10.1038/ng.249 · Cited by 531
Lowe, C. E., Cooper, J. D., Brusko, T., Walker, N. M., Smyth, D. J., Bailey, R., Bourget, K., Plagnol, V., Field, S., Atkinson, M., et al. (2007) · Nature Genetics · doi:10.1038/ng2102 · Cited by 424
Sadlack, B., Löhler, J., Schorle, H., Klebb, G., Haber, H., Sickel, E., Noelle, R. J., & Horak, I. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251111 · Cited by 423
Burchill, M. A., Yang, J., Vang, K. B., Moon, J. J., Chu, H. H., Lio, C.-W. J., Vegoe, A. L., Hsieh, C.-S., Jenkins, M. K., & Farrar, M. A. (2008) · Immunity · doi:10.1016/j.immuni.2007.11.022 · Cited by 418
Hoffmann, P., Eder, R., Boeld, T. J., Doser, K., Piseshka, B., Andreesen, R., & Edinger, M. (2006) · Blood · doi:10.1182/blood-2006-06-027409 · Cited by 407
Functional Defects and the Influence of Age on the Frequency of CD4+CD25+ T-Cells in Type 1 Diabetes
Brusko, T. M., Wasserfall, C. H., Clare-Salzler, M. J., Schatz, D. A., & Atkinson, M. A. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1407 · Cited by 398
Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity
Yamanouchi, J., Rainbow, D., Serra, P., Howlett, S., Hunter, K., Garner, V. E. S., Gonzalez-Munoz, A., Clark, J., Veijola, R., Cubbon, R., et al. (2007) · Nature Genetics · doi:10.1038/ng1958 · Cited by 368
Kovanen, P. E., & Leonard, W. J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00203.x · Cited by 360
The T Cell Protein Tyrosine Phosphatase Is a Negative Regulator of Janus Family Kinases 1 and 3
Simoncic, P. D., Lee-Loy, A., Barber, D. L., Tremblay, M. L., & McGlade, C. J. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00697-8 · Cited by 351
Cool, D. E., Tonks, N. K., Charbonneau, H., Walsh, K. A., Fischer, E. H., & Krebs, E. G. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.14.5257 · Cited by 315
Schneider, A., Rieck, M., Sanda, S., Pihoker, C., Greenbaum, C., & Buckner, J. H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7350 · Cited by 301
Self-citationKnoechel, B., Lohr, J., Kahn, E., Bluestone, J. A., & Abbas, A. K. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050855 · Cited by 296
Yu, A., Zhu, L., Altman, N. H., & Malek, T. R. (2009) · Immunity · doi:10.1016/j.immuni.2008.11.014 · Cited by 263
No Alterations in the Frequency of FOXP3+ Regulatory T-Cells in Type 1 Diabetes
Brusko, T., Wasserfall, C., McGrail, K., Schatz, R., Viener, H. L., Schatz, D., Haller, M., Rockell, J., Gottlieb, P., Clare-Salzler, M., et al. (2007) · Diabetes · doi:10.2337/db06-1248 · Cited by 253
Emerging Challenges in Regulatory T Cell Function and Biology
Sakaguchi, S., & Powrie, F. (2007) · Science · doi:10.1126/science.1142331 · Cited by 245
Cohen, A. C., Nadeau, K. C., Tu, W., Hwa, V., Dionis, K., Bezrodnik, L., Teper, A., Gaillard, M., Heinrich, J., Krensky, A. M., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.2770 · Cited by 235
FOXP3 Promoter Demethylation Reveals the Committed Treg Population in Humans
Janson, P. C. J., Winerdal, M. E., Marits, P., Thörn, M., Ohlsson, R., & Winqvist, O. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001612 · Cited by 234
Passerini, L., Allan, S. E., Battaglia, M., Di Nunzio, S., Alstad, A. N., Levings, M. K., Roncarolo, M. G., & Bacchetta, R. (2008) · International Immunology · doi:10.1093/intimm/dxn002 · Cited by 200
Interleukin-2 receptor signaling in regulatory T cell development and homeostasis
Burchill, M. A., Yang, J., Vang, K. B., & Farrar, M. A. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.08.005 · Cited by 199
IL-2 receptor alpha deficiency and features of primary biliary cirrhosis
Aoki, C. A., Roifman, C. M., Lian, Z.-X., Bowlus, C. L., Norman, G. L., Shoenfeld, Y., Mackay, I. R., & Eric Gershwin, M. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.04.005 · Cited by 174
FOXP3: Not just for regulatory T cells anymore
Ziegler, S. F. (2007) · European Journal of Immunology · doi:10.1002/eji.200636929 · Cited by 170
Moore, F., Colli, M. L., Cnop, M., Esteve, M. I., Cardozo, A. K., Cunha, D. A., Bugliani, M., Marchetti, P., & Eizirik, D. L. (2009) · Diabetes · doi:10.2337/db08-1510 · Cited by 166
Tritt, M., Sgouroudis, E., d'Hennezel, E., Albanese, A., & Piccirillo, C. A. (2008) · Diabetes · doi:10.2337/db06-1700 · Cited by 165
A Function for IL-7R for CD4+CD25+Foxp3+ T Regulatory Cells
Bayer, A. L., Lee, J. Y., de la Barrera, A., Surh, C. D., & Malek, T. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.225 · Cited by 158
Hakonarson, H. H., Qu, H., Bradfield, J. P., Marchand, L., Kim, C., Glessner, J., Grabs, R., Casalunovo, T., Taback, S. P., Frackelton, E. C., et al. (2008) · Diabetes · doi:10.2337/db07-1305 · Cited by 153
Doody, K. M., Bourdeau, A., & Tremblay, M. L. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00743.x · Cited by 101
Aoki, C. A., Borchers, A., Ridgway, W. M., KEEN, C., Ansari, A. A., & Gershwin, M. E. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.02.002 · Cited by 100
Characterization of the Murine Immunological Signaling Network with Phosphospecific Flow Cytometry
Krutzik, P. O., Hale, M. B., & Nolan, G. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2366 · Cited by 93
Zhang, S., Chen, L., Luo, Y., Gunawan, A. M., Lawrence, D. S., & Zhang, Z. (2009) · Journal of the American Chemical Society · doi:10.1021/ja903733z · Cited by 77
Self-citationCombination of rapamycin and IL-2 increases de novo induction of human CD4+CD25+FOXP3+ T cells
Long, S. A., & Buckner, J. H. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.12.012 · Cited by 72
Self-citationSgouroudis, E., Albanese, A., & Piccirillo, C. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6283 · Cited by 71
The IL-2/CD25 Pathway Determines Susceptibility to T1D in Humans and NOD Mice
Dendrou, C. A., & Wicker, L. S. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9237-9 · Cited by 58
Yu, A., & Malek, T. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5115 · Cited by 56
Long, S. A., Walker, M., Rieck, M., James, E. A., Kwok, W. W., Sanda, S., Pihoker, C., Greenbaum, C. J., Nepom, G. T., & Buckner, J. H. (2009) · European Journal of Immunology · doi:10.1002/eji.200838819 · Cited by 48
Self-citationTaylor, D. K., Walsh, P. T., LaRosa, D. F., Zhang, J., Burchill, M. A., Farrar, M. A., & Turka, L. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2216 · Cited by 19
Strieder, T. G. A., Drexhage, H. A., Lam‐Tse, W., Prummel, M. F., Tijssen, J. G. P., & Wiersinga, W. M. (2006) · Autoimmunity · doi:10.1080/08916930500508092 · Cited by 10
Tritt, M., Sgouroudis, E., d'Hennezel, E. B., Albanese, A., & Piccirillo, C. A. (2008) · Diabetes · doi:10.2337/db07-1710 · Cited by 5
Cited by
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Bluestone, J. A., Buckner, J. H., Fitch, M., Gitelman, S. E., Gupta, S., Hellerstein, M. K., Herold, K. C., Lares, A., Lee, M. R., Li, K., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad4134 · Cited by 1,033
Self-citationCD28 Costimulation: From Mechanism to Therapy
Esensten, J. H., Helou, Y. A., Chopra, G., Weiss, A., & Bluestone, J. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.020 · Cited by 937
Interleukin-2 Receptor Signaling: At the Interface between Tolerance and Immunity
Malek, T. R., & Castro, I. (2010) · Immunity · doi:10.1016/j.immuni.2010.08.004 · Cited by 851
Differentiation of diabetes by pathophysiology, natural history, and prognosis
Skyler, J. S., Bakris, G. L., Bonifacio, E., Darsow, T., Eckel, R. H., Groop, L., Groop, P.-H., Handelsman, Y., Insel, R. A., Mathieu, C., et al. (2017) · Diabetes · doi:10.2337/db16-0806 · Cited by 823
Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases
Buckner, J. H. (2010) · Nature Reviews Immunology · doi:10.1038/nri2889 · Cited by 789
Self-citation
Metadata
- Authors
- Long, S. A., Cerosaletti, K., Bollyky, P. L., Tatum, M., Shilling, H., Zhang, S., Zhang, Z.-Y., Pihoker, C., Sanda, S., Greenbaum, C., & Buckner, J. H.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-10-29
- Volume
- 59
- Issue
- 2
- Pages
- 407-415
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2115135853
- Cited by
- 283
- References
- 51
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.